Alere www.alere.com a leader in rapid diagnostics headquartered in Massachusetts has partnered with the technology company BioIQ www.bioiq.com. This partnership will offer an interface between BioIQ’s software platform “SoftSuite ™ DX, and Alere’s Cholestech LDX® System to provide immediate access to point-of-care lipid profile and glucose results for employee biometric screening events.
Employers are increasingly conducting biometric screenings to help identify at-risk employees to encourage treatment or prevention strategies to help keep them healthy and productive while reducing the economic impact of heart disease and its complications.
The employee screening events improves the testing experience for employees by making the entire screening process from scheduling, sample collection, and tracking progress readily available on smartphones and tablets through the BioIQ SoftSuite DX platform.
Also, the use of the testing technology enables employees to be tested at a wide range of healthcare facilities such as in physician offices, walk-in clinics, retail pharmacies, and through the eScreen™ Occupational Health Network (EQHN).
As Daniella Cramp, Cardiometabolic Global President for Alere explained, “With access to real-time biometric results, wellness professionals can immediately assess cardiovascular risk factors, counsel at-risk employees, refer them to medical care, and encourage enrollment in employer wellness programs.”